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ABSTRACT: The roles of ATP hydrolysis in electron-
transfer (ET) reactions of the nitrogenase catalytic cycle
remain obscure. Here, we present a new structure of a
nitrogenase complex crystallized with MgADP and
MgAMPPCP, an ATP analogue. In this structure the
two nucleotides are bound asymmetrically by the Fe-
protein subunits connected to the two diﬀerent MoFe-
protein subunits. This binding mode suggests that ATP
hydrolysis and phosphate release may proceed by a
stepwise mechanism. Through the associated Fe-protein
conformational changes, a stepwise mechanism is antici-
pated to prolong the lifetime of the Fe-protein-MoFe-
protein complex and, in turn, could orchestrate the
sequence of intracomplex ET required for substrate
reduction.
Many biological redox reactions involve transient inter-actions between a catalytic protein and a shuttle protein
that donates/accepts the reducing equivalents.1 The dynamics
of these bimolecular electron-transfer (ET) reactions are often
governed entirely by structural and physical determinants that
are built into the redox partners, such as surface interactions,
intervening protein medium between cofactors, and reduction
potentials of redox cofactors.2−4 Consequently, most inter-
protein ET reactions occur in short-lived protein-protein
encounter complexes. In contrast are a handful of enzyme
complexes that utilize nucleotide hydrolysis to regulate the
association/dissociation dynamics of redox partners.5−7 Prom-
inent among them is nitrogenase, which couples ATP
hydrolysis to the catalytic reduction of N2 into NH3:
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In nitrogenase, intermolecular ET occurs between the iron-
protein (FeP) and the catalytic molybdenum-iron protein
(MoFeP) and is coupled to hydrolysis of two ATP by FeP.
Because only one or two electrons are transferred during each
two-protein encounter, multiple cycles of complex formation
and ATP hydrolysis are required for N2 reduction. The
mechanistic imperative of ATP-coupled ET remains a central
question in biological nitrogen ﬁxation.11 Namely, why does
nitrogenase utilize ATP hydrolysis to enable the thermody-
namically favorable N2 ﬁxation reaction when many other
complex, energetically favorable multielectron/multiproton
redox reactions, including O2, H
+, CO2, SO3
2−, and NO2
−
reduction, do not? Alternatively, why is not an electron donor
like a ferredoxin or ﬂavodoxin, some of which have lower
potentials than FeP, suﬃcient to drive nitrogenase catalysis?
These questions may be germane to understanding the design
principles for other nucleotide-mediated processes as well as for
investigating conditions for N2 reduction without ATP
hydrolysis.12,13
The MoFeP-FeP complex plays a central role in the
nitrogenase mechanism as this is the species in which ATP
hydrolysis is coupled to ET. To address the coupling
mechanism, we previously reported14,15 the structure of an
ADP-AlF4
− stabilized FeP-MoFeP complex (alf-complex) that
documented an intermolecular ET pathway from the [4Fe:4S]-
cluster in the FeP homodimer (γ2) to the [8Fe:7S] P-cluster
located between each α/β pair in the MoFeP tetramer. An
additional intramolecular ET path within MoFeP was implied
between the P-cluster and the active site [7Fe:Mo:9S:1C:R-
homocitrate] FeMo-cofactor. We subsequently developed
cocrystallization conditions using near-physiological MoFeP
and FeP concentrations and ionic strength16 to capture
complexes more reﬂective of transient interactions under
turnover conditions. With this strategy, we obtained crystal
structures of three in situ formed nitrogenase complexes in
diﬀerent nucleotide states: the nucleotide-free form (nf-
complex), a form with the nonhydrolyzable ATP analog
MgAMPPCP (pcp-complex) bound, and a form with MgADP
(adp-complex) bound.16 These structures showed that FeP,
depending on the nucleotide bound, occupied distinct but
overlapping and mutually exclusive docking modes; in each
mode, the distance between the [4Fe:4S] cluster and the P-
cluster was substantially diﬀerent. In all of these structures, the
two FeP nucleotide binding sites were symmetrically occupied,
with MgADP-AlF4
−, MgAMPPCP, or MgADP, or with both
nucleotide-free. However, asymmetrically occupied nucleotide
sites are plausible as intermediates should the MgATP be
hydrolyzed in a sequential fashion, which is obligatory for the
Received: November 25, 2014
Published: December 18, 2014
Communication
pubs.acs.org/JACS
© 2014 American Chemical Society 146 DOI: 10.1021/ja511945e
J. Am. Chem. Soc. 2015, 137, 146−149
This is an open access article published under an ACS AuthorChoice License, which permits
copying and redistribution of the article or any adaptations for non-commercial purposes.
functioning of some systems such as the F1-ATPase17,18 and
AAA+ ATPases.19 Although MgADP is a potent inhibitor of
nitrogenase,20 Mortenson and Upchurch21 reported the
intriguing observation that the ATP/e− ratio decreases from
the canonical value of 2 (eq 1) to ca. 1 at higher MgADP/ATP
ratios. While this may be a manifestation of the ability of FeP to
transfer two electrons per hydrolysis of two ATPs,22 it also
raises the possibility that FeP bound with one ADP and one
ATP might be more energy eﬃcient for ET under some
metabolic states of the cell.
To better understand the role of ATP hydrolysis, we now
report the structure of a nitrogenase complex with asymmetrical
nucleotide binding of MgAMPPCP and MgADP. Together
with the previously determined structures, we have an unusually
extensive picture of a dynamic protein-protein interaction. Our
results highlight the possibility that ATP hydrolysis and
phosphate release might proceed in a stepwise fashion as
guided by the asymmetry of interactions in the MoFeP-FeP
complex, thus yielding long-lived species with discrete
intermediates.
Suitable conditions were established that yielded well-
diﬀracting crystals of a MoFeP-FeP complex in the presence
of equimolar MgADP and MgAMPPCP, a nonhydrolyzable
ATP analog, allowing the structure determination at 1.9 Å
resolution (Table S1, PDB accession code 4WZA). These
crystals are isomorphous with the previously determined pcp-
complex,16 where the asymmetric unit contains a single 2:1
FeP-MoFeP complex of subunit stoichiometry α2β2γ4 (Figure
1A). Remarkably, each FeP dimer is asymmetric with respect to
nucleotide binding and constitutes a pcp/adp-complex: the γ-
subunit positioned adjacent to the α-subunit of MoFeP
contains well-deﬁned density for MgADP, whereas the γ-
subunit interacting most closely with the β-subunit contains a
well-deﬁned MgAMPPCP (Figure 1B). The nucleotide
asymmetry is striking for two reasons: (1) the aﬃnity of FeP
for MgADP is estimated to be at least 2 orders of magnitude
tighter than that for the ATP analogues MgAMPPCP23 and
MgAMPPNP,24 suggesting FeP should predominantly be in the
MgADP-bound state in solution; (2) the MgADP and
MgAMPPCP-bound γ-subunits are uniquely associated with a
speciﬁc MoFeP subunit. Because we only observe a mixed
nucleotide structure, we can conclude the MoFeP template has
selected an otherwise minor species, suggesting that the
formation of the pcp/adp complex is favored under these
crystallization conditions.
The overall conformation of the FeP in the pcp/adp-complex,
including the docking geometry with the MoFeP, resembles
that observed previously in the pcp-complex. Nevertheless,
there are tantalizing local structural diﬀerences between the two
FeP subunits that reﬂect the asymmetric nucleotide occupancy.
Most noticeable is a ﬂip in orientation of the peptide bond
between residues Asp 129 and Val 130 in the crucial Switch II
region coupling the nucleotide binding segment to the
[4Fe:4S] cluster (Figure 2, left panel). The conformation of
this region in the FeP subunit containing the MgAMPPCP
(adjacent to the β-subunit of MoFeP) is similar in the alf-, pcp-,
and pcp/adp-complexes, while in the subunit binding MgADP
in the pcp/adp-complex, the peptide ﬂip uniquely occurs.
Although the consequence of these structural perturbations for
nucleotide hydrolysis and ET cannot be assessed here, we note
that the reduction potential of iron-sulfur clusters can be
sensitive to the orientation of peptide bonds and protein
dipoles;25 hence, the asymmetrical changes observed in the
pcp/adp-complex may be relevant to connecting the nucleotide
state to cluster oxidation states.
The FeP conformation in the pcp/adp-complex was
evaluated in the context of the larger ensemble of complexes
by principal components analysis (PCA; Figure 3) using
methods developed by Berendsen et al.26 The dominant
component (accounting for 88% of the structural variation)
closely corresponds to a hinge axis along the FeP subunit-
subunit interface, while the second component (accounting for
∼half of the remaining structural variation (7% of the total))
more closely represents a twisting motion across the interface.
Four distinct conformational categories may be identiﬁed,
corresponding to “ADP-AlF”, “ATP”, “ADP”, and “nucleotide-
free” (NF) states. The distribution of 21 FeP structures into
Figure 1. (A) FeP-MoFeP docking geometry in the pcp/adp-complex
(green and yellow, FeP γ1 and γ2 subunits; red and blue, MoFeP α
and β subunits). (B) 2F0−Fc electron density maps of the AMPPCP
and ADP nucleotides (cyan, 1σ; magenta, 4.5σ) and their interactions
with the P-loop and Switch II regions. See Figure S1 for omit electron
density maps.
Figure 2. Superpositions of the two FeP subunits in the vicinity of the
Switch II region including the [4Fe:4S] cluster and nucleotides
binding sites for the pcp/adp-, pcp-, and alf-complexes. The ﬂip in the
129−130 peptide bond orientation between the two FeP subunits is
highlighted. The yellow and green chains denote the FeP protein
predominantly interacting with the MoFeP α-and β- subunits,
respectively.
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these four groups suggests that they represent well-deﬁned local
energy minima, with the FeP conformations dependent upon
the form of bound nucleotide, type of complex formation with
the MoFeP, and potentially the FeP oxidation state. These
conformational states are associated with alternative sets of
inter- and intrasubunit salt bridges14,27 involving Glu154,
Arg187 and Arg213 that could serve to diﬀerentially stabilize
the FeP subunits in deﬁned conformations with distinct
subunit-subunit orientations (Figure S2).
While the full course of the ATP hydrolysis reaction cannot
be determined solely based on crystal structures, by combining
the new pcp/adp-complex structure with previously determined
ones, an outline can be inferred for the evolution of FeP-
MoFeP conformational states that are populated during ATP
hydrolysis (Figure 4). (1) MgATP binding commits FeP to
form an activated, multistate complex with MoFeP that is
characterized by extensive and complementary protein-protein
interactions (>3500 Å2) that are more typical of high aﬃnity
protein complexes28 than transient protein complexes with
smaller, poorly packed interfaces involved in ET.29 (2)
Alternative and mutually exclusive conformations of FeP are
populated, diﬀerentially stabilized by nucleotide and MoFeP
interactions. Diﬀerential sets of interfacial salt bridges are
generated that may stabilize these distinct species. (3) The
selective occupancy of MgADP and MgAMPPCP molecules in
the pcp/adp-complex suggests that ATP hydrolysis and/or
phosphate release proceeds through a stepwise sequence of
conformational changes16 reminiscent of the F1-ATPase17,18 or
AAA+ ATPases.19 (4) A direct implication of multiple discrete
conformations is a long-lived encounter complex. From the
turnover rate per electron under saturating conditions (∼10
s−1),30,31 the half-life for the FeP-MoFeP complex can be
estimated as ∼0.1 s. This is considerably longer than the
lifetimes of typical encounter complexes formed between
simpler ET proteins involved in one-electron exchange (τ ∼
10−3 s).32−35
Multiple discrete FeP-MoFeP states populated during ATP
hydrolysis provide a mechanism for regulation of ET by
controlling the separation between constituent metal centers.
Equally important, the lifetimes of these intermediates serve as
a timing mechanism for orchestrating underlying reactions, e.g.,
the rearrangement and reactions at the FeMo-cofactor36 and
ET between P-cluster and FeMo-cofactor. As emphasized by
Hopﬁeld37 for protein biosynthesis, the presence of quasi-
irreversible steps (such as ATP hydrolysis) in simple
Michaelis−Menten kinetic schemes eﬀectively alters the
lifetime of intermediates which allows for proof-reading of
multiple potential reaction paths. Similar arguments may be
germane to the nitrogenase reaction where ATP hydrolysis
would regulate the timing between complex formation and ET
processes; a mechanistic feature not available to simpler
electron donors such ferredoxins or small molecules. Although
FeP reduced by dithionite is a single electron donor for MoFeP,
FeP also can be reduced with low potential donors such as
ﬂavodoxin to an all-ferrous state which can donate two
electrons to MoFeP.22 The stepwise ATP hydrolysis and
phosphate release, in this case, can provide two potential
committed steps per cycle of MoFeP-FeP interaction and may
very well be an evolutionary requirement for the transfer of two
electrons in each interaction cycle. More generally, the
ensemble of conformational states observed with the nitro-
genase complex is representative of the much broader category
of nucleotide-dependent transduction systems, where ATP or
GTP hydrolysis is used to enhance the ﬁdelity of a process in
the presence of competing outcomes, e.g., protein targeting to
the appropriate cellular compartment.38
Figure 3. PCA of the crystallographically characterized FeP
conformations (complexed or uncomplexed with MoFe-protein).
Conformational space associated with the ADP-AlF4
−, ATP, ADP,
and NF conformations are highlighted. (Inset) Two perpendicular
views illustrating the orientation of the rotation axes for components 1
(purple) and 2 (cyan), which correspond to hinge bending and
twisting along the FeP dimer subunit interface. The conversion factor
between distances and rotation angles about an axis is ∼3° per Å.
Figure 4. Schematic proposal positioning crystallographically characterized Fe- and MoFe-protein structures along a reaction coordinate for ATP
hydrolysis by nitrogenase. The observation of the pcp/adp complex implicates a pathway for asymmetric ATP hydrolysis and phosphate release and,
thereby, the intermediacy of additional structural states compared to a symmetrical pathway. “T” denotes ATP (or AMPPCP). “D” denotes ADP and
“D·Pi” denotes the transition state for ATP hydrolysis. The complexes marked with asterisks indicate structurally unobserved but necessary ATP
hydrolysis intermediates that would be populated in the asymmetric pathway.
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